Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ALOGLIPTIN for Ill-defined disorder: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 11 adverse event reports in the FDA FAERS database where ALOGLIPTIN was used for Ill-defined disorder.

Most Reported Side Effects for ALOGLIPTIN

Side Effect Reports % Deaths Hosp.
Pemphigoid 98 7.1% 12 41
Pancreatitis 66 4.8% 2 41
Diarrhoea 60 4.3% 5 24
Nausea 60 4.3% 0 14
Rash 55 4.0% 1 15
Hypoglycaemia 46 3.3% 4 35
Vomiting 44 3.2% 1 19
Pancreatitis acute 43 3.1% 1 33
Drug ineffective 42 3.0% 0 9
Pruritus 42 3.0% 3 11
Condition aggravated 38 2.7% 7 27
Dizziness 34 2.5% 0 12
Interstitial lung disease 34 2.5% 4 21
Decreased appetite 33 2.4% 6 21
Headache 31 2.2% 0 6

Other Indications for ALOGLIPTIN

Type 2 diabetes mellitus (530) Diabetes mellitus (417) Product used for unknown indication (300) Blood glucose abnormal (11) Blood glucose increased (6) Hypertension (5) Suicide attempt (5)

Other Drugs Used for Ill-defined disorder

IBUPROFEN (707) ATORVASTATIN (570) DAPAGLIFLOZIN (556) SERTRALINE (437) AMLODIPINE (415) ROSUVASTATIN (361) OMEPRAZOLE (272) DOXYCYCLINE (254) PREGABALIN (248) LANSOPRAZOLE (227)

Related Pages

ALOGLIPTIN Full Profile All Ill-defined disorder Drugs ALOGLIPTIN Demographics ALOGLIPTIN Timeline